Octreotide Acetate

Brevis descriptio:


  • NOMEN OPUS:Octreotide acetate
  • Cas no:83150-76-9
  • Formulae hypotheticae:C49H66N10O10S2
  • Pondus hypotheticum:1019.26 g/mol
  • SEQUENTIA:HD-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol salis acetatis (disulfide vinculum)
  • ADVENTUS:Pulvis albus
  • APPLICANDIS:Acetas octreotide potens, longum agens syntheticum Somatostatin octapeptidum analogum, quod excrementum hormonum vetat, et adhibetur ad tumores hormona-secrendos tractare; DIABETES MELLITUS;
  • FASCICULUS:Secundum ad cutomer postulata
  • Product Detail

    Product Tags

    Keywords

    Velox Details

    • ProName:Octreotideacetate
    • CasNo: 83150-76-9
    • Formulae hypotheticae: C49H66N10O10S2
    • Aspectus: cerussa
    • Applicationem: Agri Applicationem Acromegaly Ca…
    • DeliveryTime: promptum sit amet
    • Sarcina: secundum elit scriptor requisitis
    • Portus: Shenzhen
    • ProductionCapacity: V Kilogram/mense
    • Puritas: 98%
    • Repono: 2~8℃. tuta lux
    • Transportatio: per aerem
    • LimitNum: 1 Gram

    Superioritas

    professional peptide fabrica in Sina.
    princeps qualis est gmp gradus
    magnis auctoribus pretium
    nostra producta complectitur: mole generica apis peptidis, peptide medicatura, consuetudo peptides et peptides veterinarii.
    Formulae hypotheticae.

    C49H66N10O10S2
    Relativum Missae Molecularis.
    1019.26 g/mol
    CAS-Number.
    83150-76-9 (retia), 79517-01-4 (acetate);
    Long-term PRAECLUSIO.
    -20 ± 5°C
    Synonyma.
    SMS 201-995
    Sequentia.
    HD-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol salis acetatis (disulfide vinculum)
    Agri Application.
    Acromegaly Carcinoideum syndrome VIPomas
    Substantia activa.
    Octreotide acetate longior est agens syntheticum octapeptidum analogon somatostatin naturaliter occurrens. Octreotide acetate secretionem gastro-entero-pancreaticae hormonum et emissio incrementi hormonum inhibet. Octreotide reducit motum gastrointestinalem et vetat contractionem ipsius
    vesicae fellis.
    Societas Profile:
    societas nomen:Shenzhen JYMed Technologia Co.,Ltd.
    Annus Constitutus: 2009
    Capital: 89.5 Million RMB
    Acetatum oxytocinum, acetatis vasopressinum, acetatis Desmopressin, acetatis terlipressin, acetatis Caspofungin, micafungin sodium, acetatis eptifibatidis, acetatis bivalirudin TFA, Deslorelini acetatis, acetatis glucagonis, acetatis histrelini, acetatis Caspofunginin, aceta- tis aeteris, acetatis elixatae, acetatis Bivalirudin TFA, deslorelin acetatis, glucagon. Acetate, Goserelin
    Acetate, Argireline Acetate, Metrixyl Acetate, Snap VIII, ....
    Studemus continuas innovationes in nova synthesi technologiae peptide et processu optimizationis, et nostra turma technica supra decennium experientiae in synthesi peptide.JYM feliciter multum submisit.
    of ANDA peptide APIs et producta cum CFDA formata et supra quattuor patentes approbatas habent.
    Nostra planta peptide in Nanjing sita, provincia Jiangsu et facilitatem 30,000 metrorum quadratorum posuit in obsequio cum indice cGMP. Facilitas artificiorum ab clientibus tam domesticis quam internationalibus est audita et inspecta.
    Cum praestantissima qualitate, pretiosissima et validissima subsidia technica, JYM recognitiones non solum acquisivit pro suis Institutis Investigationis et industriarum pharmaceuticae, sed etiam unus factus est ex certissimis praebitoribus peptidum in Sinis. JYM dedicatum est unum esse provisor primarius peptidis mundi in proximo futuro.

  • Priora:
  • Next:

  • Epistulam tuam hic scribe et mitte nobis